Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

According to a recent poll, over a quarter of Americans plan to turn to GLP-1 medications—like Ozempic—to reach their weight ...

The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...

Maintaining muscle mass while using GLP-1 medications requires a multi-faceted strategy. Several key components come into ...

Figuring out if GLP-1s are the right fit for you isn’t something to tackle alone—and that’s where Mochi Health comes in.

Americans are getting slimmer. The rise of GLP-1 medications has transformed the way Americans lose weight, and the data supports that: ...

Financial analyst assesses the credit market concerns and declining operating results for WW International, with insight on ...

The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...

Starting in the new year, the region’s largest health insurer will no longer cover popular diabetes drugs for the purposes of ...

The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating o ...